AMERLITE FERRITIN II ASSAY— 510(k) K952286

Substantially Equivalent

Johnson & Johnson Clinical Diagnostics, Inc.

FDA 510(k) clearance K952286 for AMERLITE FERRITIN II ASSAY, Substantially Equivalent on 1995-06-20. Applicant: Johnson & Johnson Clinical Diagnostics, Inc..

Clearance details

Applicant: Johnson & Johnson Clinical Diagnostics, Inc.
Product code: Code DBF
Advisory panel: Immunology
Date received: 1995-05-16
Decision date: 1995-06-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rochester, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.